Skip to main content

letter

. 1999 Mar;92(3):158. doi: 10.1177/014107689909200335

Statin therapy in nephrotic syndrome.

PMCID: PMC1297131 PMID: 10396279

158

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Coleman J. E., Watson A. R. Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood. Pediatr Nephrol. 1996 Apr;10(2):171–174. doi: 10.1007/BF00862065. [DOI] [PubMed] [Google Scholar]
Radhakrishnan J., Appel A. S., Valeri A., Appel G. B. The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis. 1993 Jul;22(1):135–142. doi: 10.1016/s0272-6386(12)70179-8. [DOI] [PubMed] [Google Scholar]
Warwick G. L., Packard C. J., Murray L., Grierson D., Stewart J. P., Shepherd J., Boulton-Jones J. M. Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome. Clin Sci (Lond) 1992 Jun;82(6):701–708. doi: 10.1042/cs0820701. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES